Dassault Systèmes SE

4 days ago · seekingalpha.com

Dassault Systèmes SE ( DASTY ) Q3 2026 Earnings Call October 28, 2026 9:30 AM EDT Company Participants Marie Dumas - Director of Investor Relations Pascal Daloz - Chairman & CEO Rouven Bergmann - CFO & Executive VP Conference Call Participants Jay Vleeschhouwer - Griffin Securities, Inc., Research Division Jason Celino - KeyBanc Capital Markets Inc., Research Division Derric Marcon - Bernstein Institutional Services LLC, Research Division Presentation Operator Good day, and thank you for standing by. Welcome to the Dassault Systèmes' 2026 Q3 Earnings Presentation Conference Call.

12 days ago · seekingalpha.com

Dassault Systèmes remains a quality investment, but my price target is reduced to €26.5/share, reflecting lower normalized earnings and growth expectations. Current valuation implies a 50%+ upside to PT, but the margin of safety has narrowed due to revised AEPS growth forecasts of 4–6% annually. AI-driven changes may weaken pricing power and limit incremental revenue, challenging DASTY's historical premium and justifying a lower P/E multiple of 19–22x.

18 days ago · fool.com

Taiwan Semiconductor Manufacturing (TSM -3.40%) just booked its sixth straight quarter of record profit. The world's largest contract chipmaker builds the advanced processors most of the tech industry designs but doesn't make.

28 days ago · globenewswire.com

Press Release VELIZY-VILLACOUBLAY, France — October 5, 2026                  Declaration of the number of outstanding shares and voting rights as of September 30, 2026 Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced below the total number of its outstanding shares and voting rights as of September 30, 2026, according to articles 223-16 and 221-3 of the General Regulation of the Autorité des marchés financiers. Number of outstanding shares: 1,342,945,041 Number of voting rights*: 2,018,722,012 *The total number of voting rights is calculated on the basis of the total number of outstanding shares, even if the voting rights attached thereto are suspended, pursuant to Article 223-11 of the General Regulation of the Autorité des marchés financiers relating to the method for calculating the percentages of holdings in shares and in voting rights.

1 month ago · zacks.com

Dassault Systemes (DASTY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

1 month ago · fool.com

Think -- and invest -- like a venture capitalist so your big swings carry your safe bets.

3 months ago · globenewswire.com

Press Release VELIZY-VILLACOUBLAY, France — August 7, 2026                  Declaration of the number of outstanding shares and voting rights as of July 31, 2026 Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced below the total number of its outstanding shares and voting rights as of July 31, 2026, according to articles 223-16 and 221-3 of the General Regulation of the Autorité des marchés financiers. Number of outstanding shares: 1,342,874,843 Number of voting rights*: 2,018,621,431 *The total number of voting rights is calculated on the basis of the total number of outstanding shares, even if the voting rights attached thereto are suspended, pursuant to Article 223-11 of the General Regulation of the Autorité des marchés financiers relating to the method for calculating the percentages of holdings in shares and in voting rights.

3 months ago · gurufocus.com

Dassault Systèmes (DASTY), a French software company specializing in virtual twins of complex machines, has agreed to acquire ArisGlobal, a U.S.-based enterpri

3 months ago · seekingalpha.com

Dassault Systèmes remains a hold as Q2 2026 showed Industrial Innovation growth and margin improvement, but Life Sciences revenue continues to decline. DASTY's acquisition of ArisGlobal introduces execution risk at a steep >10x sales multiple, requiring strong integration and cross-selling to justify the price. Industrial Innovation's 5% growth and customer wins suggest a return to healthy demand, but Life Sciences recovery is not yet convincing.

3 months ago · seekingalpha.com

Dassault Systèmes SE (DASTY) Q2 2026 Earnings Call Transcript